HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities research analysts at Roth Capital boosted their FY2025 EPS estimates for shares of HIVE Blockchain Technologies in a research note issued to investors on Monday, January 6th. Roth Capital analyst D. Aftahi now forecasts that the company will earn ($0.54) per share for the year, up from their prior estimate of ($0.55). Roth Capital currently has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q1 2026 earnings at ($0.10) EPS, Q3 2026 earnings at ($0.04) EPS, FY2027 earnings at $0.23 EPS and FY2028 earnings at ($0.10) EPS.
Several other equities research analysts have also weighed in on the company. Northland Capmk raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Thursday, September 19th. Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- How to buy stock: A step-by-step guide for beginnersÂ
- Why AMD Stock Might Already Be This Year’s Best Buy
- Investing In Preferred Stock vs. Common Stock
- 3 Promising Penny Stocks to Watch for Long-Term Gains in 2025
- Consumer Staples Stocks, Explained
- The 3 Kings of Buybacks in 2024: Can They Do It Again?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
